“The integration of CHAPPER healthcare into the AscellaHealth organization consolidates overall global market leadership, unlocking new opportunities for market access and product commercialization ...
We have developed a fully synthetic lung surfactant preparation, based on designed analogues of surfactant proteins SP-B and SP-C, for treatment of respiratory distress syndrome in premature infants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback